A Study to Assess the PK and Safety of PT010 in Subjects With COPD Following Single and Repeat Dose

Trial Identifier: PT010018
Sponsor: Pearl Therapeutics, Inc.
NCTID:: NCT03250182
Start Date: August 2017
Primary Completion Date: December 2017
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation

Trial Locations

Country Location
United States of America, FL Clearwater, FL, United States of America, 33765